DCAT

DCAT Week 2025: Sustainability in Medical Propellants
March 24, 2025

PharmTech Group chatted with Markus Laubscher of Orbia during DCAT Week 2025, covering the topics of sustainability, regulatory hurdles, next-generation innovation, and the DCAT Week experience.

SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025
March 19, 2025

The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.

DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
March 19, 2025

Russell Miller, vice-president of Global Sales & Marketing at Enzene, explains that continuous bioprocessing is poised to change biologics manufacturing moving forward.

DCAT Week 2025: Enzymatic RNA Synthesis
March 19, 2025

PharmTech Group spoke with Alison Moore, chief technical officer, Codexis to find out the latest about the RNA therapy market and to get perspective on how enzymatic RNA synthesis is used to synthesize RNA molecules.

DCAT Week 2025: Keeping Up with Drug Demand
March 19, 2025

PharmTech Group sat down with Anil Kane of Thermo Fisher Scientific live on site at DCAT Week 2025, to talk about technologies and digital solutions companies are using to meet demand across the bio/pharma industry.

DCAT Week 2025: Expanding Sterile Injectables Capacity
March 18, 2025

PharmTech Group interviewed Lee Karras of Noramco live on site at DCAT Week 2025, shortly after the company announced a $25 million investment in sterile injectable manufacturing capabilities at its Halo Pharma facility in New Jersey.

DCAT Week 2025: Impact of Geopolitical Climate on Biopharma
March 18, 2025

PharmTech sat down with Joseph Principe, chief commercial officer at Abzena ahead of DCAT Week 2025 to get his perspective on how the geopolitical climate is impacting the industry.

DCAT Week 2025: Quality and Compliance for Animal-derived Products
March 18, 2025

Pharmaceutical Technology® discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry with Roger Viney, chief commercial officer of ICE Pharma.

DCAT Week 2025: A Discussion on Aseptic Processing for Sterile Injectable Manufacturing
March 18, 2025

Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceutical manufacturing.

DCAT Week 2025: Recognizing the Value of CDMOs
March 18, 2025

Pharmaceutical Technology® chats with Simon Wright from Almac Pharma Services about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.